miR-4461 Inhibits Liver Cancer Stem Cells Expansion and Chemoresistance via Regulating SIRT1.

Yang, Daji; Zhang, Ping; Yang, Ziting; Hou, Guojun; Yang, Ziyu

Yang, Daji; Zhang, Ping; Yang, Ziting; Hou, Guojun; Yang, Ziyu.

Afiliación

Yang D; Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Xinmin Street, Changchun, 130021, China.
Zhang P; Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Xinmin Street, Changchun, 130021, China.
Yang Z; Department of Emergency, The 964th Hospital of the Chinese People's Liberation Army, Changchun, China.
Hou G; Department of Hepatic Surgery, Third Affiliated Hospital of Second Military Medical University, Shanghai, 200438, China.
Yang Z; Department of Integrative Medicine, Third Affiliated Hospital of Second Military Medical University, Shanghai, 200438, China.

Carcinogenesis ; 2022 Nov 28.

Article en En | MEDLINE | ID: mdl-36437743

Palabras clave

Hepatocellular carcinoma; SIRT1; TACE; cancer stem cells; miR-4461

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Carcinogenesis Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google